Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Downgrades Snap to Perform

Oppenheimer Downgrades Snap to Perform

Oppenheimer analyst Jason Helfstein downgrades Snap (NYSE:SNAP) from Outperform to Perform.

byBenzinga Newsdesk

July 22, 2022

1 minute read

Oppenheimer analyst Jason Helfstein downgrades Snap (NYSE:SNAP) from Outperform to Perform.

Stephens & Co. Maintains Overweight on Business First Bancshares, Raises Price Target to $30

By Benzinga Newsdesk

October 28, 10:14 AM

Stephens & Co. analyst Matt Olney maintains Business First Bancshares (NASDAQ:BFST) with a Overweight and raises the price target from $29 to $30.

BFST

50% THC Infused Pre-Rolls For Medical Marijuana Patents Now Available, Thanks To This Pot Giant

By Vuk Zdinjak

August 1, 11:14 AM

Aurora Cannabis (NASDAQ: ACB) (TSX:ACB) launched its first high-potency infused pre-roll for medical cannabis patients, with more than 50% total THC.

ACB

Analyst Ratings

The Latest Analyst Ratings For Houlihan Lokey

By Benzinga Insights

February 5, 3:00 PM

Across the recent three months, 4 analysts have shared their insights on Houlihan Lokey (NYSE:HLI), expressing a variety…

HLI

Summer Take Off? JetBlue Plans Two New Routes From Puerto Rico

By Shivani Kumaresan

April 20, 12:11 PM

JetBlue Airways Corporation (NASDAQ:JBLU) is launching two new routes from Puerto Rico, bringing more low-fare flights. Starting this summer, JetBlue…

JBLU

Oppenheimer Downgrades Snap to Perform

Related Posts

Stephens & Co. Maintains Overweight on Business First Bancshares, Raises Price Target to $30

50% THC Infused Pre-Rolls For Medical Marijuana Patents Now Available, Thanks To This Pot Giant

The Latest Analyst Ratings For Houlihan Lokey

Summer Take Off? JetBlue Plans Two New Routes From Puerto Rico